Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Cognitive impairment in HSCT recipients

    Author:
    HT Staff
    Publish date: February 21, 2018

    New research suggests the risk of cognitive impairment after hematopoietic stem cell transplant (HSCT) is greatest among recipients of...

    • Read More

    News

    AYA cancer patients lost to follow-up

    Author:
    HT Staff
    Publish date: February 20, 2018

    ORLANDO—Many adolescent and young adult (AYA) cancer survivors don’t continue with follow-up care, according to a new study. Researchers analyzed...

    • Read More

    News

    Intervention helps kids stay active after cancer treatment

    Author:
    HT Staff
    Publish date: February 19, 2018

    ORLANDO—Results of a pilot study suggest a web-based, reward-driven intervention can motivate adolescent cancer survivors to stay physically...

    • Read More

    News

    Study reveals lack of sexual aids for cancer survivors

    Author:
    HT Staff
    Publish date: February 18, 2018

    ORLANDO—A new study suggests many US cancer centers do not have therapeutic aids for patients who experience sexual dysfunction after cancer...

    • Read More

    News

    FDA grants ivosidenib NDA priority review

    Author:
    HT Staff
    Publish date: February 17, 2018

    The US Food and Drug Administration (FDA) has accepted for priority review the new drug application (NDA) for ivosidenib, a targeted inhibitor of...

    • Read More

    News

    NK-cell therapy in resistant MDS, AML

    Author:
    HT Staff
    Publish date: February 16, 2018

    Results of a phase 1/2 trial suggest treatment with haploidentical natural killer (NK) cells can be effective against relapsed/refractory...

    • Read More

    News

    Team creates device to study hemostasis

    Author:
    HT Staff
    Publish date: February 16, 2018

    Researchers have engineered a miniature model system for studying hemostasis. They believe the device could serve as a drug discovery platform...

    • Read More

    News

    Drug receives orphan designation for MM

    Author:
    HT Staff
    Publish date: February 16, 2018

    The US Food and Drug Administration (FDA) has granted orphan designation to PT-112 as a treatment for multiple myeloma (MM). PT-112 is a small-...

    • Read More

    News

    ASCO, NCCN release guidelines on checkpoint inhibitors

    Author:
    HT Staff
    Publish date: February 15, 2018

    Two cancer organizations have released guidelines for managing the side effects of immune checkpoint inhibitors. The American Society of Clinical...

    • Read More

    News

    Product seems effective for ITI in severe hemophilia A

    Author:
    HT Staff
    Publish date: February 15, 2018

    Results of a retrospective study suggest a recombinant factor VIII Fc fusion protein (rFVIIIFc) can be effective for immune tolerance induction (...

    • Read More

    News

    Young kids with SCA not receiving recommended prophylaxis

    Author:
    HT Staff
    Publish date: February 14, 2018

    Many young children with sickle cell anemia (SCA) may not be taking the recommended antibiotics to prevent invasive pneumococcal disease (IPD),...

    • Read More

    News

    JAK2 inhibition could reduce risk of GVHD

    Author:
    HT Staff
    Publish date: February 14, 2018

    Preclinical research suggests that targeting JAK2 can reduce the risk of graft-versus-host disease (GVHD) in transplant recipients. Researchers...

    • Read More

    News

    Child’s cancer diagnosis can affect mother’s income long-term

    Author:
    HT Staff
    Publish date: February 14, 2018

    A study conducted in Sweden revealed that social benefits can ease financial burdens for parents of children recently diagnosed with cancer....

    • Read More

    News

    Product increases FIX levels in hemophilia B

    Author:
    HT Staff
    Publish date: February 13, 2018

    MADRID—The recombinant factor IX (FIX) product CB 2679d/ISU304 can increase FIX levels in patients with severe hemophilia B, according to a phase...

    • Read More

    News

    Agent can decrease GI toxicity in MM patients

    Author:
    HT Staff
    Publish date: February 13, 2018

    Results of a case-control study suggest a cytoprotective agent can reduce treatment-related gastrointestinal (GI) toxicity in patients with...

    • Read More

    Pages

    • « first
    • …
    • 27
    • 28
    • 29
    • 30
    • 31
    • 32
    • 33
    • 34
    • 35
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery